Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jaseng Medi-bio is a South Korean biotechnology company and a subsidiary of the Jaseng Medical Foundation, specializing in the development and manufacturing of traditional Korean medicine (TKM) based pharmaceuticals and health supplements. The company focuses on scientific validation of herbal remedies, particularly those used in the treatment of musculoskeletal disorders such as spinal disc herniation and arthritis. Jaseng Medi-bio operates advanced manufacturing facilities that comply with Good Manufacturing Practice (GMP) standards to produce standardized herbal extracts and finished products. Their research efforts are closely integrated with the Jaseng Spine Hospital network, aiming to bridge the gap between traditional oriental medicine and modern evidence-based biotechnology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jaseng Medi-bio.